L. Ellis

The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid.

R. Coleman, J. Tidy, B. Hancock, 2013, European journal of cancer.

Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.

J. Lipton, J. Kuruvilla, Vikas Gupta, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours

N. Sebire, M. Seckl, M. Wells, 2019, British Journal of Cancer.

Initial presenting features in gestational trophoblastic neoplasia: does a decade make a difference?

J. Cook, J. Tidy, B. Hancock, 2012, Journal of reproductive medicine.

Deaths from gestational trophoblastic neoplasia: any lessons to be learned?

R. Coleman, B. Hancock, L. Ellis, 2012, The Journal of reproductive medicine.

A comparison of long-term outcomes of donor lymphocyte infusions and tyrosine kinase inhibitors in patients with relapsed CML after allogeneic hematopoietic cell transplantation.

S. Kamel‐Reid, J. Lipton, E. Atenafu, 2014, Clinical lymphoma, myeloma & leukemia.

Molecular relapse after allogeneic hematopoietic cell transplant for chronic myeloid leukemia: some long-term survivors appear to tolerate even lack of major molecular response

S. Kamel‐Reid, J. Lipton, E. Atenafu, 2014, Leukemia & lymphoma.